Top

Published in:

01-06-2021 | SARS-CoV-2 | Review Article

Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?

Authors: Andrea Stracciari, Gabriella Bottini, Maria Guarino, Eugenio Magni, Leonardo Pantoni, on behalf of the “Cognitive and Behavioral Neurology” Study Group of the Italian Neurological Society

Published in: Neurological Sciences | Issue 6/2021

Abstract

Patients with COVID-19 are increasingly reported to suffer from a wide range of neurological complications, affecting both the central and peripheral nervous system. Among central manifestations, cognitive and behavioral symptoms are to date not exhaustively detailed. Furthermore, it is not clear whether these represent a combination of non-specific complications of a severe systemic disease, not differing from those usually seen in patients suffering from heterogenous pathological conditions affecting the central nervous system, or instead, they are a peculiar expression of COVID-19 neurotropism; in other words, if the infection has a coincidental or causal role in such patients. We examined both hypotheses, reporting opposite points of view, with the aim to stimulate discussion and raise awareness of the topic.

This position is mainly sustained by LP and EM.

This position is mainly sustained by GB and MG.

Due to AS.

Guan WJ, Νi ZY, Hu Y, Liang W, Ou C, He J et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032CrossRefPubMed

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5CrossRefPubMedPubMedCentral

Gupta A, Mahesh V, Madhavan MV, Sehgal K, Nair N, Mahajan S et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26:1017–1032. https://doi.org/10.1038/s41591-020-0968-3CrossRefPubMed

Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR (2020) Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents 56. https://doi.org/10.1016/j.ijantimicag2020.106024

Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, Forma A, Karakuła K, Flieger W, Portincasa P, Maciejewski R (2020) COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. J Clin Med 9:1753. https://doi.org/10.3390/jcm9061753CrossRefPubMedCentral

Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH (2020) Extrapulmonary complications of COVID-19: a multisystem disease? J Med Virol 2020:1–13. https://doi.org/10.1002/jmv.26294CrossRef

Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, Warnke C (2020) A systematic review of neurological symptoms and complications of COVID-19. J Neurol 268:392–402. https://doi.org/10.1007/s00415-020-10067-3CrossRefPubMedPubMedCentral

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurological manifestations of hospitalized patients with COVID-19 in Wuhan. China JAMA Neurol 77:683–690. https://doi.org/10.1001/jamaneurol.2020.1127CrossRefPubMed

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020(382):2268–2270. https://doi.org/10.1056/NEJMc2008597CrossRef

10.

Asadi-Pooya AA, Simani L (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413. https://doi.org/10.1016/j.jns.2020.116832

11.

Ahmad I, Rathore FA (2020) Neurological manifestations and complications of COVID-19: a literature review. J Neurol Sci 77:8–12. https://doi.org/10.1016/j.jocn.2020.05.017CrossRef

12.

Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, Alberici A, Baldelli E, Benini M, Bonacina S, Brambilla L, Caratozzolo S, Cortinovis M, Costa A, Cotti Piccinelli S, Cottini E, Cristillo V, Delrio I, Filosto M, Gamba M, Gazzina S, Gilberti N, Gipponi S, Imarisio A, Invernizzi P, Leggio U, Leonardi M, Liberini P, Locatelli M, Masciocchi S, Poli L, Rao R, Risi B, Rozzini L, Scalvini A, Schiano di Cola F, Spezi R, Vergani V, Volonghi I, Zoppi N, Borroni B, Magoni M, Pezzini A, Padovani A (2020) Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology 95:910–920. https://doi.org/10.1212/WNL.0000000000009848CrossRef

13.

Leonardi M, Padovani A, McArthur JC (2020) Neurological manifestations associated with COVID-19: a review and a call for action. J Neurol 267:1573–1576. https://doi.org/10.1007/s00415-020-09896-zCrossRefPubMedPubMedCentral

14.

Pilotto A, Benussi A, Libri I, Masciocchi S, Poli L, Premi E, Alberici A, Baldelli E, Bonacina S, Brambilla L, Benini M, Caratozzolo S, Cortinovis M, Costa A, Cotti Piccinelli S, Cottini E, Cristillo V, Delrio I, Filosto M, Gamba M, Gazzina S, Gilberti N, Gipponi S, Giunta M, Imarisio A, Liberini P, Locatelli M, Schiano F, Rao R, Risi B, Rozzini L, Scalvini A, Vergani V, Volonghi I, Zoppi N, Borroni B, Magoni M, Leonardi M, Zanusso G, Ferrari S, Mariotto S, Pezzini A, Gasparotti R, Paolillo C, Padovani A (2020) COVID-19 impact on consecutive neurological patients admitted to the emergency department. J Neurol Neurosurg Psychiatry 92:218–220. https://doi.org/10.1136/jnnp-2020-323929CrossRefPubMed

15.

Beach RS, Praschan NC, Hogan C, Dotson S, Merideth F, Kontos N et al (2020) Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry 65(2020):47–53. https://doi.org/10.1016/j.genhosppsych.2020.05.008CrossRefPubMedPubMedCentral

16.

Whittaker A, Matthew Anson M (2020) Harky A (2020) Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand 00:1–9. https://doi.org/10.1111/ane.13266CrossRef

17.

Tsivgoulis G, Palaiodimous L, Katsanos AH, Caso V, Köhrmann M, Molina C et al (2020) Neurological manifestations and implications of COVID-19. Pandemic Ther Adv Neurol Disord 2020(13):1–14. https://doi.org/10.1177/1756286420932036CrossRef

18.

Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS et al (2020) Neurological complications of coronavirus infection: a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci 417:117085. https://doi.org/10.1016/j.jns.2020.117085CrossRefPubMedPubMedCentral

19.

Pryce-Roberts A, Talaei M, Robertson NP Neurological complications of COVID-19: a preliminary review. J Neurol 267:1870–1873. https://doi.org/10.1007/s00415-020-09941-x

20.

Niazkar HR, Zibaee B, Nasimi A, Narjes B (2020) The neurological manifestations of COVID-19: a review article. Neurol Sci doi https://doi.org/10.1007/s10072-020-04486-3

21.

Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, Karim AH, Sattar A (2020) Neurological manifestations of COVID-19 (SARS-CoV-2): a review. Front Neurol 11:518. https://doi.org/10.3389/fneur.2020.00518CrossRefPubMedPubMedCentral

22.

Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, Jayaseelan DL, Kumar G, Raftopoulos RE, Zambreanu L, Vivekanandam V, Khoo A, Geraldes R, Chinthapalli K, Boyd E, Tuzlali H, Price G, Christofi G, Morrow J, McNamara P, McLoughlin B, Lim ST, Mehta PR, Levee V, Keddie S, Yong W, Trip SA, Foulkes AJM, Hotton G, Miller TD, Everitt AD, Carswell C, Davies NWS, Yoong M, Attwell D, Sreedharan J, Silber E, Schott JM, Chandratheva A, Perry RJ, Simister R, Checkley A, Longley N, Farmer SF, Carletti F, Houlihan C, Thom M, Lunn MP, Spillane J, Howard R, Vincent A, Werring DJ, Hoskote C, Jäger HR, Manji H, Zandi MS (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143:3104–3120. https://doi.org/10.1093/brain/awaa240CrossRefPubMedPubMedCentral

23.

Ellul MA, Benjamin L, Singh B, Lant S, Benedict DM, Easton A et al (2020) Neurological associations of COVID-19. Lancet Neurol 19:767–783. https://doi.org/10.1016/S1474-4422(20)30221-0CrossRefPubMedPubMedCentral

24.

Matschke J, Lütgehetmann M, Hagel C, Sperhake JP, Schröder AS, Edler C, Mushumba H, Fitzek A, Allweiss L, Dandri M, Dottermusch M, Heinemann A, Pfefferle S, Schwabenland M, Sumner Magruder D, Bonn S, Prinz M, Gerloff C, Püschel K, Krasemann S, Aepfelbacher M, Glatzel M (2020 Nov) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19(11):919–929. https://doi.org/10.1016/S1474-4422(20)30308-2CrossRefPubMedPubMedCentral

25.

Aghagoli G, Gallo Marin B, Katchur NJ, Chaves-Sell F, Asaad WF, Murphy SA (2020) Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care 13:1–10. https://doi.org/10.1007/s12028-020-01049-4CrossRef

26.

Ticinesi A, Cerundolo N, Parise A, Nouvenne A, Prati B, Guerra A et al (2020) Delirium in COVID-19: epidemiology and clinical correlations in a large group of patients admitted to an academic hospital. Aging Clin Exp Res 32:2159–2166. https://doi.org/10.1007/s40520-020-01699-6CrossRefPubMedPubMedCentral

27.

Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS (2020) Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7:611–627. https://doi.org/10.1016/S2215-0366(20)30203-0CrossRefPubMedPubMedCentral

28.

Hsieh SJ, Soto GJ, Hope AA, Ponea A, Gong MN (2015) The association between acute respiratory distress syndrome, delirium, and in-hospital mortality in intensive care unit patients. Am J Respir Crit Care Med 191:71–78. https://doi.org/10.1164/rccm.201409-1690OCCrossRefPubMedPubMedCentral

29.

Hopkins RO, Weaver LK, Chan KJ, Orme JF Jr (2004) Quality of life, emotional, and cognitive function following acute respiratory distress syndrome. J Int Neuropsychol Soc 10:1005–1017. https://doi.org/10.1017/s135561770410711xCrossRefPubMed

30.

Bianchetti A, Rozzini R, Guerini F, Boffelli S, Ranieri P, Minelli G, Bianchetti L, Trabucchi M (2020) Clinical presentation of COVID19 in dementia patients. J Nutr Health Aging 24:560–562. https://doi.org/10.1007/s12603-020-1389-1CrossRefPubMedPubMedCentral

31.

Wilson MH, Newman S, Imray CH (2009) The cerebral effects of ascent to high altitudes. Lancet Neurol 8:175–191. https://doi.org/10.1016/S1474-4422(09)70014-6CrossRefPubMed

32.

Howard RS (2007) Neurological problems on the ICU. Clinical medicine (London, England) 7:148–153. https://doi.org/10.7861/clinmedicine.7-2-148)CrossRef

33.

Pilotto A, Masciocchi S, Volonghi I, Crabbio M, Magni E, De Giuli V, Caprioli F, Rifino N, Sessa M, Gennuso M, Cotelli MS, Turla M, Balducci U, Mariotto S, Ferrari S, Ciccone A, Fiacco F, Imarisio A, Risi B, Benussi A, Premi E, Focà E, Caccuri F, Leonardi M, Gasparotti R, Castelli F, Zanusso G, Pezzini A (2021) Padovani A; SARS-CoV-2 related encephalopaties (ENCOVID) Study Group. Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study. J Infect Dis 223(1):28-37. https://doi.org/10.1093/infdis/jiaa609

34.

Sasannejad C, Ely EW, Lahiri S (2019) Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care 23:352. https://doi.org/10.1186/s13054-019-2626-zCrossRefPubMedPubMedCentral

35.

Edén A, Kanberg N, Gostner J, Fuchs D, Hagberg L, Andersson LM, Lindh M, Price RW, Zetterberg H, Gisslén M (2020) CSF biomarkers in patients with COVID-19 and neurological symptoms: a case series. Neurology 12(96):e294–e300. https://doi.org/10.1212/WNL.0000000000010977CrossRef

36.

Politi LS, Salsano E, Grimaldi M (2020) Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol 77:1028–1029. https://doi.org/10.1001/jamaneurol.2020.2125CrossRefPubMed

37.

Eliezer M, Hamel AL, Houdart E, Herman P, Housset J, Jourdaine C, Eloit C, Verillaud B, Hautefort C (2020) Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts. Neurology. 95:e3145–e3152. https://doi.org/10.1212/WNL.0000000000010806CrossRefPubMed

38.

Lovati C, Osio M, Pantoni L (2020) Diagnosing herpes simplex-1 encephalitis at the time of COVID-19 pandemic. Neurol Sci 41:1361–1364. https://doi.org/10.1007/s10072-020-04461-yCrossRefPubMed

39.

Scopelliti G, Osio M, Arquati M, Pantoni L (2020) Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19. Neurol Sci 17:1–3. https://doi.org/10.1007/s10072-020-04826-3CrossRef

40.

Beatriz Lara B, Carnes A, Dakterzada F, Benitez I, Piñol-Ripoll G (2020) Neuropsychiatric symptoms and quality of life in Spanish Alzheimer’s disease patients during COVID-19 lockdown. Eur J Neurol 27:1744–1747. https://doi.org/10.1111/ene.14339CrossRef

41.

Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ (2020) The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 395(10227):912–920. https://doi.org/10.1016/S0140-6736(20)30460-8CrossRefPubMedPubMedCentral

42.

Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW, BRAIN-ICU Study Investigators (2013) BRAIN-ICU study investigators. Long-term cognitive impairment after critical illness. N Engl J Med 369:1306–1316. https://doi.org/10.1056/NEJMoa1301372CrossRefPubMedPubMedCentral

43.

Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, Shi C, Hu S (2020) The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res 129:98–102CrossRefPubMedPubMedCentral

44.

Negrini F, Ferrario I, Mazziotti D, Berchicci M, Bonazzi M, de Sire A, Negrini S, Zapparoli L (2021) Neuropsychological features of severe hospitalized COVID-19 patients at clinical stability and clues for post-acute rehabilitation. Arch Phys Med Rehabil 102:155–158. https://doi.org/10.1016/j.apmr.2020.09.376CrossRefPubMed

45.

Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J (2020) Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 9:100163. https://doi.org/10.1016/j.bbih.2020.100163CrossRefPubMedPubMedCentral

46.

Steardo L, Zorec R, Verkhratsky A (2020) Neuroinfection may potentially contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxford) 229:e13473. https://doi.org/10.1111/apha.13473CrossRef

47.

Suzuki M, Saito K, Min W-P, Vladau C, Toida K, Itoh H, Murakami S (2007) Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope 117:272–277. https://doi.org/10.1097/01.mlg.0000249922.37381.1eCrossRefPubMedPubMedCentral

48.

TWH C, Sridhar S, Zhang AJ, Chan KH, Li HL, FKC W, Yuen KY (2020) Olfactory dysfunction in coronavirus disease 2019 patients: observational cohort study and systematic review. Open Forum Infect Dis 7:ofaa199. https://doi.org/10.1093/ofid/ofaa199CrossRef

49.

Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 277:2251–2261. https://doi.org/10.1007/s00405-020-05965-1CrossRefPubMedPubMedCentral

50.

Neumann B, Schmidbauer ML, Dimitriadis K, Otto S, Knier B, Niesen WD, Hosp JA, Günther A, Lindemann S, Nagy G, Steinberg T, Linker RA, Hemmer B, Bösel J, PANDEMIC and the IGNITE study groups (2020) Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms. J Neurol Sci 418:117090. https://doi.org/10.1016/j.jns.2020.117090CrossRefPubMedPubMedCentral

51.

Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikkema L et al (2020) Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specifc expression of mediators of SARS-CoV-2 viral entry and highlights infammatory programs in putative target cells. bioRxiv 04(19):049254. https://doi.org/10.1101/2020.04.19.049254CrossRef

52.

Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 7:875–882. https://doi.org/10.1016/S2215-0366(20)30287-XCrossRefPubMedPubMedCentral

53.

Zayet S, Ben Abdallah Y, Royer PY, Toko L, Gendrin V, Klopfenstein T (2020) Encephalopathy in patients with COVID-19: “causality or coincidence?”. J Med Virol 93:1193. https://doi.org/10.1002/jmv.26027CrossRefPubMed

54.

Cani I, Barone V, D’Angelo R, Pisani L, Allegri V, Spinardi L, Malpassi P, Fasano L, Rinaldi R, Fanti S, Cortelli P, Guarino M (2020) Frontal encephalopathy related to hyperinflammation in COVID-19. J Neurol 11:1–4. https://doi.org/10.1007/s00415-020-10057-5CrossRef

55.

Muccioli L, Pensato U, Cani I, Guarino M, Cortelli P, Bisulli F (2020) COVID-19–associated encephalopathy and cytokine-mediated neuroinflammation. Ann Neurol 88:860–861. https://doi.org/10.1002/ana.25855CrossRefPubMed

56.

Pensato U, Muccioli L, Pasini E, Tappatà M, Ferri L, Volpi L, Licchetta L, Battaglia S, Rossini G, Bon I, Re MC, Cirillo L, Simonetti L, Gramegna LL, Michelucci R, Cortelli P, Zini A, Bisulli F (2020) Encephalopathy in COVID-19 presenting with acute aphasia mimicking stroke. Front Neurol 11:587226. https://doi.org/10.3389/fneur.2020.587226CrossRefPubMedPubMedCentral

57.

Koralnik IJ, Tyler KL (2020) COVID-19: a global threat to the nervous system. Ann Neurol 88:1–11. https://doi.org/10.1002/ana.25807CrossRefPubMedPubMedCentral

58.

Muccioli L, Pensato U, Cani I, Guerra L, Provini F, Bordin G, Riccioli LA, Lodi R, Tinuper P, Bisulli F (2020) COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment. J Neuroimmunol 349:577400. https://doi.org/10.1016/j.jneuroim.2020.577400CrossRefPubMedPubMedCentral

59.

Chaumont H, San-Galli A, Martino F, Couratier C, Joguet G, Carles M, Roze E, Lannuzel A (2020) Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection. J Neurol 267:3121–3127. https://doi.org/10.1007/s00415-020-09986-yCrossRefPubMedPubMedCentral

60.

Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P, Boullet A, Doukhi D, le Guennec L, Godefroy N, Maatoug R, Fossati P, Millet B, Navarro V, Bruneteau G, Demeret S, Pourcher V, the CoCo‐Neurosciences study group and COVID SMIT PSL study group (2020) COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol 27:2651–2657. https://doi.org/10.1111/ene.14478CrossRefPubMed

61.

Filatov A, Sharma P, Hindi F, Espinosa PS (2020) Neurological complications of coronavirus disease (COVID-19) encephalopathy. Cureus 12:7352. https://doi.org/10.7759/cureus.7352CrossRef

62.

Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, Nocivelli S, Pezzini A, Focà E, Caruso A, Leonardi M, Pasolini MP, Gasparotti R, Castelli F, Ashton NJ, Blennow K, Zetterberg H, Padovani A (2020) Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol 88:423–427. https://doi.org/10.1002/ana.25783CrossRefPubMedPubMedCentral

63.

Perrin P, Collongues N, Baloglu S, Bedo D, Bassand X, Lavaux T, Gautier-Vargas G, Keller N, Kremer S, Fafi-Kremer S, Moulin B, Benotmane I, Caillard S (2021) Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol 28:248–258. https://doi.org/10.1111/ene.14491CrossRefPubMed

64.

Galanopoulou AS, Ferastraoaru V, Correa DJ, Cherian K, Duberstein S, Gursky J, Hanumanthu R, Hung C, Molinero I, Khodakivska O, Legatt AD, Patel P, Rosengard J, Rubens E, Sugrue W, Yozawitz E, Mehler MF, Ballaban-Gil K, Haut SR, Moshé SL, Boro A (2020) EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: a small case series preliminary report. Epilepsia Open 5:314–324. https://doi.org/10.1002/epi4.12399CrossRefPubMedPubMedCentral

65.

Pasini E, Bisulli F, Volpi L, Minardi I, Tappatà M, Muccioli L, Pensato U, Riguzzi P, Tinuper P, Michelucci R (2020) EEG findings in COVID-19 related encephalopathy. Clin Neurophysiol 131:2265–2267. https://doi.org/10.1016/j.clinph.2020.07.003CrossRefPubMedPubMedCentral

66.

Vellieux G, Rouvel-Tallec A, Jaquet P, Grinea A, Sonneville R, d’Ortho MP (2020) COVID-19 associated encephalopathy: is there a specific EEG pattern? Clin Neurophysiol 131:1928–1930. https://doi.org/10.1016/j.clinph.2020.06.005CrossRefPubMedPubMedCentral

67.

Shiahaan YMT, Puspitasari V, Rinaldi Pangestu A. (2020) COVID-19-associated encephalitis: systematic review of case reports. Findings on Cytokine Immune-Mediated Inflammation as an Underlying Mechanism. Research Square https://orcid.org/0000-0003-3785-3077 DOI: 10.21203/rs.3.rs-65579/v1

68.

Pugin D, Vargas MI, Thieffry C, Schibler M, Grosgurin O, Pugin J, Lalive PH (2020) COVID-19-related encephalopathy responsive to high doses glucocorticoids. Neurology 95:543–546. https://doi.org/10.1212/WNL.0000000000010354CrossRefPubMed

69.

Dogan L, Kaya D, Sarikaya T, Zengin R, Dincer A, Akinci IO, Afsar N (2020) Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series. Brain Behav Immun 87:155–158. https://doi.org/10.1016/j.bbi.2020.05.022CrossRefPubMedPubMedCentral

70.

Bernard-Valnet R, Pizzarotti B, Anichini A, Demars Y, Russo E, Schmidhauser M, Cerutti-Sola J, Rossetti AO, du Pasquier R (2020) Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur J Neurol 27:43–44. https://doi.org/10.1111/ene.14298CrossRef

71.

Zhang C, Wu Z, Li JW, Zhao H, Wang GQ (2020) Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents 55:105954. https://doi.org/10.1016/j.ijantimicag.2020.105954CrossRefPubMedPubMedCentral

72.

Majid F, Ali M, Somayeh M, Cyrus R (2020) Neurobiology of COVID-19. J Alzheimers Dis 76:3–19. https://doi.org/10.3233/JAD-200581CrossRef

73.

Rubin DB, Danish HH, Ali AB, Li K, LaRose S, Monk AD, Cote DJ, Spendley L, Kim AH, Robertson MS, Torre M, Smith TR, Izzy S, Jacobson CA, Lee JW, Vaitkevicius H (2019) Neurological toxicities associated with chimeric antigen receptor T-cell therapy. Brain 142:1334–1348. https://doi.org/10.1093/brain/awz053CrossRefPubMed

74.

Santomasso B, Bachier C, Westin J, Rezvani K, Shpall EJ (2019) The other side of CAR T-cell therapy: cytokine release syndrome, neurologic toxicitly, and financial burden. Am Soc Clin Oncol Educ Book 39:433–444. https://doi.org/10.1200/EDBK_238691CrossRefPubMed

75.

Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN, Maus MV, Park JH, Mead E, Pavletic S, Go WY, Eldjerou L, Gardner RA, Frey N, Curran KJ, Peggs K, Pasquini M, DiPersio JF, van den Brink MRM, Komanduri KV, Grupp SA, Neelapu SS (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25:625–638. https://doi.org/10.1016/j.bbmt.2018.12.758CrossRefPubMed

76.

Santomasso BD, Park JH, Salloum D, Riviere I, Flynn J, Mead E, Halton E, Wang X, Senechal B, Purdon T, Cross JR, Liu H, Vachha B, Chen X, DeAngelis LM, Li D, Bernal Y, Gonen M, Wendel HG, Sadelain M, Brentjens RJ (2018) Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia. Cancer Discov 8:958–971. https://doi.org/10.1158/2159-8290.CD-17-1319CrossRefPubMedPubMedCentral

77.

Strati P, Ahmed S, Kebriaei P, Nastoupil LJ, Claussen CM, Watson G, Horowitz SB, Brown ART, Do B, Rodriguez MA, Nair R, Shpall EJ, Green MR, Neelapu SS, Westin JR (2020) Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma. Blood Adv 4:3123–3127. https://doi.org/10.1182/bloodadvances.2020002328CrossRefPubMedPubMedCentral

Title: Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?
Authors: Andrea Stracciari
Gabriella Bottini
Maria Guarino
Eugenio Magni
Leonardo Pantoni
on behalf of the “Cognitive and Behavioral Neurology” Study Group of the Italian Neurological Society
Publication date: 01-06-2021
Publisher: Springer International Publishing
Keywords: SARS-CoV-2
COVID-19
Cytokines
Encephalopathy
Published in: Neurological Sciences / Issue 6/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05231-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2021

Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations

Authors’ reply to Bugiani O: More focus on SENECA with CAA

Dynamic functional connectivity in temporal lobe epilepsy: a graph theoretical and machine learning approach

The influence of statin withdrawal and adherence on stroke outcomes

Osmotic demyelination syndrome and leukoencephalopathy in FGF23-related hypophosphatemia: a case report

Association of gender and age at onset with glucocerebrosidase associated Parkinson’s disease: a systematic review and meta-analysis